Atul Bioscience Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 29.02 Cr
as on 17-11-2024
- Company Age 27 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 42.50 Cr
as on 17-11-2024
- Satisfied Charges ₹ 58.75 Cr
as on 17-11-2024
- Revenue 25.11%
(FY 2023)
- Profit -97.35%
(FY 2023)
- Ebitda -28.71%
(FY 2023)
- Net Worth -7.13%
(FY 2023)
- Total Assets -6.90%
(FY 2023)
About Atul Bioscience
The Corporate was formerly known as Atul Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 29.02 Cr.
The company currently has active open charges totaling ₹42.50 Cr. The company has closed loans amounting to ₹58.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Atul Bioscience Limited India are Sandip Bole as CFO and Mohit Patel as Company Secretary. Sunil Lalbhai, Gopi Thirukonda, Pramod Lele, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ1997PLC032369
- Company No.
032369
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 May 1997
- Date of AGM
12 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Atul Bioscience?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhakar Chebiyyam  | Managing Director | 11-Jul-2014 | Current |
| Sandip Bole | CFO | 01-May-2022 | Current |
| Mohit Patel | Company Secretary | 20-Apr-2023 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Gadre | Director | 21-Apr-2022 | Current |
| Sunil Lalbhai | Director | 11-Dec-2008 | Current |
| Pramod Lele | Director | 19-Jan-2011 | Current |
| Gopi Thirukonda | Director | 21-May-1997 | Current |
| Rangaswamy Iyer | Director | 19-Jan-2011 | Current |
| Latika Pradhan | Director | 22-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Atul Bioscience.
Atul Bioscience Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.11% increase. The company also saw a substantial fall in profitability, with a 97.35% decrease in profit. The company's net worth dipped by a decrease of 7.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atul Bioscience?
In 2023, Atul Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Jul 2024 | ₹40.00 Cr | Open |
Axis Bank Limited Creation Date: 07 Jun 2011 | ₹2.50 Cr | Open |
Others Creation Date: 08 Mar 2019 | ₹40.00 Cr | Satisfied |
How Many Employees Work at Atul Bioscience?
Atul Bioscience has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atul Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atul Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
